Total Knee Arthroplasty (TKA) Coverage Criteria
Customize your policy alerts
Sign up for globalhealth Policy S-560 alerts
Get alerted when Policy S-560 changes without checking for updates manually.
Monitor payer policy activity
Policy governing medical necessity coverage criteria for FDA-approved total knee arthroplasty prostheses for GlobalHealth commercial members, including safety, clinical indications, and coding guidance.
Changed smoking criteria to include counseling on effects of smoking on surgical outcomes and treatment for smoking cessation if accepted.
Medical Necessity and Coverage Criteria
Medical necessity criteria for TKA
Covered when ALL of the following safety requirements are met AND at least ONE of the listed clinical indications is present:
Safety requirements
- BMI: Body Mass Index less than 40BMI < 40
[[chunk 0]]
- Smoking: Documented confirmation that patient is a nonsmoker, has refrained from smoking for at least 4 weeks prior to planned surgery, or has received counseling on the effects of smoking on surgical outcomes and treatment for smoking cessation if accepted
[[chunks 0,4]]
- Glycemic control: Hemoglobin A1c less than 8% in patients with diabetesA1c < 8%
[[chunk 0]]
- Ambulation: Must be able to ambulate pre-operatively within the home and/or be expected to return to ambulation within 3 days post-operative with assistive deviceReturn to ambulation within 3 days
[[chunk 0]]
- Life-limiting conditions: Absence of an active, life-limiting condition that would likely cause death before recovery from surgery
[[chunk 0]]
- Post-op plan: Development of a pre-operative plan for post-operative return to function
[[chunk 0]]
Clinical indications (one or more required)
- Degenerative joint disease with ALL: presence of significant radiographic findings (knee joint destruction, angular deformity, or severe narrowing); trial and failure of optimal medical management (oral or topical NSAIDs, acetaminophen, or intra-articular corticosteroid injection); documented failure or patient not candidate for more conservative measures (e.g., osteotomy); and treatment indicated due to disabling pain or functional disability
[[chunk 0]]
- Failed osteotomy: Failure of previous proximal tibial or distal femoral osteotomy
[[chunk 0]]
- Posttraumatic destruction: Posttraumatic knee joint destruction
[[chunk 0]]
- Distal femur fracture in elderly: Distal femur fracture repair in elderly patient with osteoporosis
[[chunk 1]]
- Limb salvage for malignancy
[[chunk 1]]
- Congenital deformity
[[chunk 4]]
- Hemophilic arthropathy
[[chunk 4]]
- Revision indications: Replacement (revision) of previous arthroplasty for disabling pain; functional disability; progressive and substantial bone loss (osteolysis); dislocation of patella; aseptic component instability; infection; or periprosthetic fracture
[[chunk 4]]
This policy applies to FDA‑approved total knee arthroplasty (TKA) prostheses for GlobalHealth commercial members and defines the medical necessity criteria that must be satisfied for coverage. Coverage is contingent on meeting all specified safety requirements (for example, BMI < 40, smoking status or documented cessation counseling, glycemic control where applicable, pre‑operative ambulation ability, absence of active life‑limiting conditions, and a documented pre‑operative plan for post‑operative return to function) and on meeting at least one of the listed clinical indications such as degenerative joint disease, posttraumatic destruction, failed osteotomy, or other specified indications. The document does not list separate cosmetic or experimental exclusions beyond the stated safety and indication requirements.
Procedures that fail to meet the policy’s explicit safety requirements or lack documented indication are not supported as medically necessary. Examples include patients with BMI ≥ 40, uncontrolled diabetes with hemoglobin A1c ≥ 8% when applicable, absence of required smoking documentation or cessation counseling, inability to ambulate pre‑operatively without expectation of return to ambulation within 3 days post‑op, presence of an active life‑limiting condition likely to cause death before recovery, or absence of documented trial and failure of conservative management for degenerative joint disease.
CPT and Administrative Coding
| 27447 | arthroplasty, knee, condyle and plateau: medical and lateral compartments w/wo patella resurfacing (total knee arthroplasty) |
Provider Requirements, Prior Authorization, and Documentation
Prior authorization required for CPT 27447 and 27486–27487
Prior authorization is required for CPT 27447 (primary total knee arthroplasty) and CPT 27486–27487 (revision total knee arthroplasty). Submit documentation with the authorization request that demonstrates the member meets the policy criteria (safety requirements and applicable clinical indication).
Conservative management (trial and failure) required
Document a trial and failure of optimal medical management for degenerative joint disease before TKA. Examples of therapies that must be tried and failed are listed in the policy.
- Oral non-steroidal anti-inflammatory drugs (NSAIDs)
- Topical NSAIDs
- Acetaminophen
- Intra-articular corticosteroid injection
Required documentation to support TKA coverage
Include the following clinical and risk‑factor data in the medical record and authorization submission to support medical necessity for TKA.
- Body Mass Index (document numeric BMI) demonstrating BMI < 40
- Smoking status OR documentation of counseling on smoking effects and any smoking‑cessation treatment if accepted
- Hemoglobin A1c for patients with diabetes (document A1c < 8%)
- Pre‑operative ambulation status and expectation of return to ambulation within 3 days post‑op with assistive device
- Radiographic findings supporting degenerative joint disease and records of failed conservative treatments
- Pre‑operative plan for post‑operative return to function/rehabilitation plan
Documentation deficiencies may lead to denial
Failure to document required safety measures or failed conservative management may result in denial of coverage for the procedure.
- Missing documentation of BMI < 40
- No record of smoking status or lack of counseling/cessation treatment when applicable
- Absence of recent hemoglobin A1c for diabetic patients or A1c ≥ 8%
- No documentation of pre‑operative ambulation ability or post‑op rehabilitation plan
- Lack of records showing trial and failure of listed conservative treatments
Clinical Background and Indications
Total knee arthroplasty is indicated for advanced degenerative joint disease that produces disabling pain or functional disability after a trial and failure of optimal medical management (for example, oral or topical NSAIDs, acetaminophen, or intra‑articular corticosteroid injection). Appropriate radiographic evidence (such as joint destruction, angular deformity, or severe joint‑space narrowing) and documentation that conservative measures have failed or are not appropriate are required before TKA is considered medically necessary. Preoperative optimization (weight management, smoking cessation or counseling, glycemic control) and a plan for postoperative return to function are emphasized to reduce perioperative risk and support successful outcomes.
Key Definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.